These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Successful treatment of relapsed and refractory multiple myeloma by using clarithromycin-lenalidomide, low-dose dexamethasone(BiRd), and melphalan-prednisolone(MP)]. Tsunemine H, Yoshioka S, Sakane E, Akasaka H, Ito K, Kodaka T, Takahashi T. Gan To Kagaku Ryoho; 2015 May; 42(5):605-7. PubMed ID: 25981655 [Abstract] [Full Text] [Related]
23. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol]. Marisavljević D, Bosković D, Radosević N, Elezović I, Tomin D, Gotić M, Antunović P. Srp Arh Celok Lek; 1996 May; 124(11-12):292-6. PubMed ID: 9132962 [Abstract] [Full Text] [Related]
24. Pleural plasmacytomas - the role of radiotherapy. Yeoh KW, Thitsar SM, Master Z, Loh Y, Chen Y, Nagarajan C, Tin KM, Cutter D, Mikhaeel G. Br J Haematol; 2020 Aug; 190(3):e160-e162. PubMed ID: 32519756 [No Abstract] [Full Text] [Related]
26. Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP). Eom HS, Kim YK, Chung JS, Kim K, Kim HJ, Kim HY, Jin JY, Do YR, Oh SJ, Suh C, Seong CM, Kim CS, Lee DS, Lee JH. Ann Hematol; 2010 May; 89(5):489-97. PubMed ID: 20012045 [Abstract] [Full Text] [Related]
29. Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure. Tosi P, Zamagni E, Cellini C, Cangini D, Tacchetti P, Tura S, Baccarani M, Cavo M. Eur J Haematol; 2004 Aug; 73(2):98-103. PubMed ID: 15245508 [Abstract] [Full Text] [Related]
30. Low-dose thalidomide for multiple myeloma: interim analysis of a compassionate use program. Steurer M, Spizzo G, Mitterer M, Gastl G. Onkologie; 2004 Apr; 27(2):150-4. PubMed ID: 15138347 [Abstract] [Full Text] [Related]
31. [Efficacy of thalidomide combined dexamethasone on newly diagnosed multiple myeloma]. Yuan ZG, Hou J, Wang DX, Fu WJ, Chen YB, Xi H. Ai Zheng; 2007 Dec; 26(12):1369-72. PubMed ID: 18076804 [Abstract] [Full Text] [Related]
33. Myelomatous effusion with poor response to chemotherapy. Kim YM, Lee KK, Oh HS, Park SK, Won JH, Hong DS, Park HS, Park JS, Lee DW. J Korean Med Sci; 2000 Apr; 15(2):243-6. PubMed ID: 10803706 [Abstract] [Full Text] [Related]
34. Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma. Schütt P, Ebeling P, Buttkereit U, Brandhorst D, Opalka B, Hoiczyk M, Flasshove M, Hense J, Bojko P, Metz K, Moritz T, Seeber S, Nowrousian MR. Eur J Haematol; 2005 Jan; 74(1):40-6. PubMed ID: 15613105 [Abstract] [Full Text] [Related]
35. Primary extramedullary plasmacytoma with diffuse lymph node involvement: a case report and review of the literature. Naymagon L, Abdul-Hay M. J Med Case Rep; 2019 May 22; 13(1):153. PubMed ID: 31113466 [Abstract] [Full Text] [Related]
36. Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma. Palumbo A, Giaccone L, Bertola A, Pregno P, Bringhen S, Rus C, Triolo S, Gallo E, Pileri A, Boccadoro M. Haematologica; 2001 Apr 22; 86(4):399-403. PubMed ID: 11325646 [Abstract] [Full Text] [Related]
39. [Successful treatment with lenalidomide plus dexamethasone for multiple myeloma complicated with systemic amyloidosis]. Fuchida S, Okano A, Hatsuse M, Murakami S, Haruyama H, Shimazaki C. Rinsho Ketsueki; 2012 Nov 22; 53(11):1937-9. PubMed ID: 23257677 [Abstract] [Full Text] [Related]